Clariscan is a macrocyclic, general purpose gadolinium-based contrast agent, used to enhance visualization in MRI procedures across a range of indications. Manufactured by GE Healthcare in a range of packaging options and has a well established tolerability profile.
Contact Clinical Sales SpecialistWhy surgeons prefer Clariscan
- Macrocyclic structure - Macrocyclic, ionic chelate provides high kinetic and themodynamic stability.
- Expertly manufactured - Quality manufacture and delivery, expertly managed by GE for greatest control.
- Established tolerability - Over 17 million patient administrations, with low level of adverse events.
- Convenient packaging options - Vials, prefilled syringes and +PLUSPAK bottles in a range of volumes.
- Stability: Gadoteric acid has the highest kinetic and thermodynamic stability of GBCAs. This can help to reduce the risk of gadolinium dissociation.
- Tolerability: Building confidence with low allergic reaction rates compared with other GBCA’s.
- Dependability: The REMIND study investigated the non-inferiority of gadoteric acid vs gadobutrol for visualization and characterization of primary brain tumor.
